• Return to Headlines

Shares of Myriad Genetics Down on Above Average Volume, Moving Against Trend (MYGN)

By Nick Russo

Myriad Genetics's stock is down 39.4% to $26.98 on heavy trading volume. About 1.9 million shares have been traded today, as compared to the 30-day average volume of 1.3 million shares. Unusually high volume can signify a potential turning point or validate a breakout.

SmarTrend recommended that subscribers consider buying shares of Myriad Genetics on July 1st, 2019 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $27.87. Since that recommendation, shares of Myriad Genetics have risen 59.8%. We continue to monitor MYGN for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

In the past 52 weeks, shares of Myriad Genetics have traded between a low of $22.07 and a high of $50.44 and are now at $27.96, which is 27% above that low price. Over the last five market days, the 200-day moving average (MA) has remained constant while the 50-day MA has advanced 4.4%.

Keywords: unusual volume myriad genetics

Ticker(s): MYGN